⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SLDB News
Solid Biosciences Inc. Common Stock
Solid Biosciences Announces European Commission Orphan Designation for SGT-212 and Continued Progress in the FALCON Trial in Friedreich’s Ataxia
globenewswire.com
SLDB
Solid Biosciences to Present Research Across Gene Therapy Development, Delivery and Manufacturing at ESGCT 2026
globenewswire.com
SLDB
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
SLDB
Solid Biosciences to Participate at Upcoming Investor Conferences
globenewswire.com
SLDB
Form 8-K
sec.gov
SLDB
Solid Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Updates
globenewswire.com
SLDB
Solid Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Updates
globenewswire.com
SLDB
Duchenne Muscular Dystrophy Treatment Market Report (2025-2034) Published, Segments Intravenous, Subcutaneous, and Oral Routes Across Three Pharmacy Channels
globenewswire.com
SRPT
PFE
BIIB
REGN
GILD
JNJ
ABBV
NVS
SNY
CAPR
SLDB
WVE
EDIT
Parent Project Muscular Dystrophy Hosts 2026 Annual Conference in Orlando, Florida
prnewswire.com
CAPR
SRPT
CATX
BMRA
EDSA
ENTX
SLDB
WVE
Form 8-K
sec.gov
SLDB